Matinas BioPharma Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
MTNB$1.24+4.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
| Item 2. | Properties |
|---|
Our administrative offices consist of approximately 500 square feet of office space in Bedminster, NJ that we occupy under a lease that expires in December 2026. We also lease laboratory space approximating 14,000 square feet in Bridgewater, NJ, that expires in September 2027.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.